Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Self-assembling protein nanoparticles in the design of vaccines. Local targets link to admitted publications; unresolved targets remain external evidence.
The global value of vaccination
10.1016/s0264-410x(02)00623-0 · 2003 · External reference
10.1073/pnas.1402981111
10.1073/pnas.1402981111 · External reference
Treatment of drug-resistant Shigella infections
10.1586/14787210.2015.983902 · 2015 · External reference
10.1073/pnas.1400472111
10.1073/pnas.1400472111 · External reference
An abnormal protein associated with tobacco mosaic virus infection
10.1038/169419a0 · 1952 · External reference
10.1128/jvi.7.5.569-576.1971
10.1128/jvi.7.5.569-576.1971 · External reference
10.1016/s0264-410x(99)00434-x
10.1016/s0264-410x(99)00434-x · External reference
10.1038/nri2868
10.1038/nri2868 · External reference
Adaptations of nanoscale viruses and other protein cages for medical applications
10.1016/j.nano.2006.07.009 · 2006 · External reference
Influenza virus-like particles as pandemic vaccines
2009 · External reference
Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses
10.1586/erv.10.89 · 2010 · External reference
The basic architecture of viruses
10.1007/978-94-007-6552-8_2 · 2013 · External reference
10.1146/annurev.biophys.29.1.105
10.1146/annurev.biophys.29.1.105 · External reference
There's plenty of room at the bottom
1960 · External reference
10.1016/j.sbi.2004.06.006
10.1016/j.sbi.2004.06.006 · External reference
10.1073/pnas.78.9.5275
10.1073/pnas.78.9.5275 · External reference
10.1016/j.sbi.2013.06.002
10.1016/j.sbi.2013.06.002 · External reference
10.1016/s0021-9258(18)68927-6
10.1016/s0021-9258(18)68927-6 · External reference
Symmetry, flexibility and permeability in the structure of yeast retrotransposon virus-like particles
10.1002/j.1460-2075.1992.tb05156.x · 1992 · External reference
Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein
10.1038/330381a0 · 1987 · External reference
10.1126/science.2425433
10.1126/science.2425433 · External reference
Presentation of hepatitis B virus preS2 epitope on bluetongue virus core-like particles
10.1016/0042-6822(92)90922-c · 1992 · External reference
Chimeric parvovirus B19 capsids for the presentation of foreign epitopes
10.1006/viro.1994.1059 · 1994 · External reference
Expression of tobacco mosaic virus coat protein and assembly of pseudovirus particles in Escherichia coli
10.1073/pnas.91.19.9067 · 1994 · External reference
Three-dimensional structure of a mouse-adapted type 2/type 1 poliovirus chimera
10.1002/j.1460-2075.1991.tb07772.x · 1991 · External reference
Infectious enveloped RNA virus antigenic chimeras
10.1073/pnas.89.1.207 · 1992 · External reference
Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases
10.1056/nejmoa061760 · 2007 · External reference
10.1016/s0140-6736(07)60946-5
10.1016/s0140-6736(07)60946-5 · External reference
10.3390/ijms160613106
10.3390/ijms160613106 · External reference
10.1038/nrmicro2893
10.1038/nrmicro2893 · External reference
10.1021/acs.chemrev.5b00109
10.1021/acs.chemrev.5b00109 · External reference
Nanoparticles as synthetic vaccines
10.1016/j.copbio.2015.03.014 · 2015 · External reference
10.1586/14760584.6.5.797
10.1586/14760584.6.5.797 · External reference
Insect cells as a production platform of complex virus-like particles
10.1586/erv.12.153 · 2013 · External reference
10.1002/biot.201400387
10.1002/biot.201400387 · External reference
10.1126/science.6272395
10.1126/science.6272395 · External reference
10.1038/298347a0
10.1038/298347a0 · External reference
Human hepatitis B vaccine from recombinant yeast
10.1038/307178a0 · 1984 · External reference
Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B
2003 · External reference
Prophylactic human papillomavirus vaccines
10.1172/jci28607 · 2006 · External reference
10.1016/0092-8674(86)90071-1
10.1016/0092-8674(86)90071-1 · External reference
10.1073/pnas.88.11.4646
10.1073/pnas.88.11.4646 · External reference
Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic
10.1073/pnas.89.24.12180 · 1992 · External reference
Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles
10.1128/jvi.67.4.1936-1944.1993 · 1993 · External reference
Crystal structures of four types of human papillomavirus L1 capsid proteins: understanding the specificity of neutralizing monoclonal antibodies
10.1074/jbc.m706380200 · 2007 · External reference
Maturation of the human papillomavirus 16 capsid
10.1128/mbio.01104-14 · 2014 · External reference
Structural comparison of four different antibodies interacting with human papillomavirus 16 and mechanisms of neutralization
10.1016/j.virol.2015.04.016 · 2015 · External reference
A cryo-electron microscopy study identifies the complete H16.V5 epitope and reveals global conformational changes initiated by binding of the neutralizing antibody fragment
10.1128/jvi.02898-14 · 2015 · External reference
Human papillomavirus infection and the primary and secondary prevention of cervical cancer
10.1002/cncr.23704 · 2008 · External reference
Assembly of double-shelled rotaviruslike particles by simultaneous expression of recombinant VP6 and VP7 proteins
10.1128/jvi.65.12.6994-6997.1991 · 1991 · External reference
Synthesis of immunogenic, but non-infectious, poliovirus particles in insect cells by a baculovirus expression vector
10.1099/0022-1317-70-6-1453 · 1989 · External reference
Assembly of herpes simplex virus (HSV) intermediate capsids in insect cells infected with recombinant baculoviruses expressing HSV capsid proteins
10.1128/jvi.68.4.2442-2457.1994 · 1994 · External reference
10.1006/meth.1999.0843
10.1006/meth.1999.0843 · External reference
Electron microscopy of hepatitis B core antigen synthesized in E. coli
10.1038/296677a0 · 1982 · External reference
Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy
10.1038/386088a0 · 1997 · External reference
10.1016/0092-8674(94)90142-2
10.1016/0092-8674(94)90142-2 · External reference
Immunological properties of hepatitis B core antigen fusion proteins
10.1073/pnas.87.7.2545 · 1990 · External reference
10.1016/0168-1656(95)00118-2
10.1016/0168-1656(95)00118-2 · External reference
10.1128/iai.72.11.6519-6527.2004
10.1128/iai.72.11.6519-6527.2004 · External reference
From the circumsporozoite protein to the RTS, S/AS candidate vaccine
10.4161/hv.6.1.9677 · 2010 · External reference
A phase 3 trial of RTS, S/AS01 malaria vaccine in African infants
10.1056/nejmoa1208394 · 2012 · External reference
10.1345/aph.1aq634
10.1345/aph.1aq634 · External reference
10.1016/s0140-6736(15)60721-8
10.1016/s0140-6736(15)60721-8 · External reference
10.1517/13543784.16.11.1775
10.1517/13543784.16.11.1775 · External reference
Virus-like particle based vaccines for Alzheimer disease
10.4161/hv.6.11.12655 · 2010 · External reference
10.1016/s0140-6736(10)60206-1
10.1016/s0140-6736(10)60206-1 · External reference
10.2217/fmb.10.22
10.2217/fmb.10.22 · External reference
10.1038/nature12966
10.1038/nature12966 · External reference
A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses
10.1016/s0264-410x(02)00266-9 · 2002 · External reference
Virus-like particles: passport to immune recognition
10.1016/j.ymeth.2006.07.018 · 2006 · External reference
Expression and self-assembly of empty virus-like particles of hepatitis E virus
10.1128/jvi.71.10.7207-7213.1997 · 1997 · External reference
Long-term efficacy of a hepatitis E vaccine
10.1056/nejmoa1406011 · 2015 · External reference
10.1016/s0140-6736(10)61030-6
10.1016/s0140-6736(10)61030-6 · External reference
Influenza virus-like particle vaccines
10.1586/erv.09.8 · 2009 · External reference
Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins
10.1128/jvi.75.13.6154-6165.2001 · 2001 · External reference
10.1089/vim.2005.18.244
10.1089/vim.2005.18.244 · External reference
10.1016/j.vaccine.2013.07.043
10.1016/j.vaccine.2013.07.043 · External reference
10.1016/j.vaccine.2015.03.009
10.1016/j.vaccine.2015.03.009 · External reference
10.1056/nejmc1313186
10.1056/nejmc1313186 · External reference
Characterization of Humoral Responses Induced by an H7N9 Influenza Virus-Like Particle Vaccine in BALB/C Mice
10.3390/v7082821 · 2015 · External reference
10.1128/mbio.01044-15
10.1128/mbio.01044-15 · External reference
Pandemic influenza vaccine: characterization of A/California/07/2009 (H1N1) recombinant hemagglutinin protein and insights into H1N1 antigen stability
10.1186/1472-6750-12-77 · 2012 · External reference
10.1177/2051013615595595
10.1177/2051013615595595 · External reference
10.1586/erv.13.3
10.1586/erv.13.3 · External reference
Improved characteristics and protective efficacy in an animal model of E. coli-derived recombinant double-layered rotavirus virus-like particles
10.1016/j.vaccine.2014.01.093 · 2014 · External reference
10.1586/erv.12.152
10.1586/erv.12.152 · External reference
10.1586/14760584.2015.1073110
10.1586/14760584.2015.1073110 · External reference
10.1586/erv.12.145
10.1586/erv.12.145 · External reference
10.1128/jvi.66.11.6527-6532.1992
10.1128/jvi.66.11.6527-6532.1992 · External reference
10.1016/j.jmb.2009.04.078
10.1016/j.jmb.2009.04.078 · External reference
Structural description of the active sites of mouse L-chain ferritin at 1.2 A resolution
10.1007/s00775-002-0389-4 · 2003 · External reference
Solving the structure of human H ferritin by genetically engineering intermolecular crystal contacts
10.1038/349541a0 · 1991 · External reference
10.1038/nature12202
10.1038/nature12202 · External reference
10.1038/nm.3927
10.1038/nm.3927 · External reference
10.1016/j.cell.2015.07.043
10.1016/j.cell.2015.07.043 · External reference
10.1038/srep12501
10.1038/srep12501 · External reference
10.1073/pnas.1012923107
10.1073/pnas.1012923107 · External reference
10.1371/journal.pone.0099881
10.1371/journal.pone.0099881 · External reference
10.1126/science.1234150
10.1126/science.1234150 · External reference
Flavins and Flavoproteins
2014 · External reference
Multiple assembly states of lumazine synthase: a model relating catalytic function and molecular assembly
10.1016/j.jmb.2006.07.037 · 2006 · External reference
Formation of protein micelles from amphiphilic membrane proteins
10.1073/pnas.75.11.5306 · 1978 · External reference
10.1371/journal.pone.0050852
10.1371/journal.pone.0050852 · External reference
A randomized, blinded, controlled, dose-ranging study of a respiratory syncytial virus recombinant fusion (F) nanoparticle vaccine in healthy women of childbearing age
2015 · External reference
10.1016/j.vaccine.2014.04.016
10.1016/j.vaccine.2014.04.016 · External reference
10.1016/j.nano.2006.04.007
10.1016/j.nano.2006.04.007 · External reference
Design of peptide nanoparticles using simple protein oligomerization domains
10.2174/1875933500902010015 · 2009 · External reference
10.1111/j.1747-0285.2008.00746.x
10.1111/j.1747-0285.2008.00746.x · External reference
10.1111/j.1747-0285.2012.01423.x
10.1111/j.1747-0285.2012.01423.x · External reference
10.4049/jimmunol.0901957
10.4049/jimmunol.0901957 · External reference
10.1016/s0959-440x(02)00350-0
10.1016/s0959-440x(02)00350-0 · External reference
10.1073/pnas.041614998
10.1073/pnas.041614998 · External reference
10.1126/science.1219351
10.1126/science.1219351 · External reference
10.1038/nnano.2011.122
10.1038/nnano.2011.122 · External reference
10.1038/nchem.2107
10.1038/nchem.2107 · External reference
Nanobiotechnology: protein arrays made to order
10.1038/nnano.2011.127 · 2011 · External reference
10.1126/science.1219364
10.1126/science.1219364 · External reference
10.1371/journal.pone.0020450
10.1371/journal.pone.0020450 · External reference
10.1073/pnas.97.19.10383
10.1073/pnas.97.19.10383 · External reference
10.1038/nature09304
10.1038/nature09304 · External reference
10.1038/nature13404
10.1038/nature13404 · External reference
10.1016/b978-0-12-381270-4.00019-6
10.1016/b978-0-12-381270-4.00019-6 · External reference
10.1038/mtm.2014.48
10.1038/mtm.2014.48 · External reference
CYT-006-AngQb, a vaccine against angiotensin II for the potential treatment of hypertension
2009 · External reference
Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8(+) T-cell responses in melanoma patients
10.1002/eji.201142361 · 2012 · External reference
Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine
10.1016/s0264-410x(02)00260-8 · 2002 · External reference
10.1056/nejmoa1101245
10.1056/nejmoa1101245 · External reference
Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice
10.1073/pnas.93.11.5335 · 1996 · External reference
10.1128/jvi.65.5.2702-2706.1991
10.1128/jvi.65.5.2702-2706.1991 · External reference
10.1007/s10549-009-0666-9
10.1007/s10549-009-0666-9 · External reference
A virosomal vaccine against candidal vaginitis: immunogenicity, efficacy and safety profile in animal models
10.1016/j.vaccine.2012.04.069 · 2012 · External reference
10.1371/journal.pone.0055438
10.1371/journal.pone.0055438 · External reference
Inflexal V a trivalent virosome subunit influenza vaccine: production
10.1016/s0264-410x(02)00512-1 · 2002 · External reference
10.1046/j.1468-1293.2001.00080.x
10.1046/j.1468-1293.2001.00080.x · External reference
